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Summary The aim of our work was quantitative evaluation of the protein and phospholipid fractions of mature erythrocyte membranes
separated from women with ovarian cancer. Blood was sampled from 30 women with ovarian cancer, aged 24-79 years, in the third stage of
clinical progression of the disease. Phospholipids were separated from membranes by MOller's acidic extraction method and analysed in thin-
layer two-dimensional chromatography. On the silica gel plates nine fractions of phospholipids were separated: sphingomyelin (SPH),
phosphatidylethanolamine (PE), phosphatidlyserine (PS), phosphatidylcholine (PC), lysophosphatidylcholine (LPC), phosphatidic acid (PA),
phosphatidylinositol (Ptd Ins), phosphatidylinositol-4-phosphate (Ptd Ins-4-P), phosphatidylinositol-4,5-diphosphate (Ptd Ins-4,5-P2). The
activity of phospholipase C in erythrocyte membranes was determined by Akhrem's spectrophotometric method. Membrane proteins were
separated by polyacrylamide gel electrophoresis, SDS-PAGE. It was shown that PS, SPH, LPC and PA fractions were significantly
diminished. The concentration of Ptd Ins-4-P and Ptd Ins-4,5-P2 was significantly increased with simultaneous reduction in Ptd Ins level. The
inhibition of phospholipase C reached 80%. The quantitative protein evaluation showed a statistically significant decrease in spectrin and a
significant increase in 4.1 protein. The quantitative changes, observed in phospholipid and protein fractions, led to the restructuring of the
erythrocyte membrane cytoskeleton, which may be connected to increased susceptibility to haemolysis of red blood cells.
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Ovarian cancer is a common pathology among women over 50
years of age. Up to 2% of the female population will develop
ovarian cancer during their lifetime. Cancer exerts a multidirec-
tional influence on the human organism, leading to systemic
disturbances. Mature red blood cells are a good experimental
model and an easily obtainable material to study these changes.
Although erythrocyte does not contain subcellular organelles it is a
highly autonomic and specialized cell. That is why many biochem-
ical transformations, difficult to evaluate in otherexperimental cell
studies, are easily observed in erythrocytes. However, little atten-
tion has been directed to the effects of cancer on the structure of
erythrocyte membrane. Lipids and proteins (Byers et al, 1985;
Derick et al, 1992) are the fundamental elements of erythrocyte
membrane skeleton. Phospholipids as a basic component of
erythrocyte membrane determine its shape and structure and also
the influence of external factors on intracellular metabolism
(Ferrel et al, 1984; Schwartz et al, 1985; Smith, 1987). Erythrocyte
membrane phospholipids are asymmetrically distributed in the two
halves of the membrane bilayer. The choline-containing phospho-
lipids phosphatidylcholine and sphingomyelin (PC and SPH) are
present mainly in the outer monolayer, whereas the amino-
phospholipids phosphatidylethanolamine and phosphatidylserine
(PE and PS) are placed almost exclusively in the inner monolayer.
Membrane skeleton is formed of three major (spectrin, actin and
ankirin) and several minor peripheral membrane proteins and is
associated with the cytoplasmic face of the membrane bilayer
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through protein-protein and protein-phospholipid interactions
(Branton et al, 1981; Sikorski et al, 1993a). This association has
been considered the main factor in maintaining the asymmetric
phospholipid distribution across the erythrocyte membrane
bilayer. Disturbances in phospholipid composition of erythrocyte
membranes result in spherocytic or sickle cell anaemias, and
changes of shape shortening the lifespan of erythrocytes are
observed (Gudi et al, 1990).
Phospholipids, particularly inositol derivates, perform many
important functions in the membrane metabolism (Lubin, 1981).
They influence the metabolic activity ofcalcium ions in cells. The
inositol-containing phospholipids play a critical role in coordi-
nating cellular activity because they furnish cells with a number of
intracellular signal molecules in response to a wide variety of
hormones, neurotransmitters and growth factors (Barwijuk, 1989).
It is generally accepted that upon agonist activation many cell
receptors stimulate a phospholipase C (PLC) that cleaves phos-
phatidylinositol-4,5-diphosphate (Ptd Ins-4, 5-P2) to give diacyl-
glycerol, which remains associated with the membrane, and
inositoltriphosphate (Ins P3), which diffuses into the cytosol (Bolt
et al, 1993). Diacylglycerol is a second messenger, which activates
protein kinase C (PKC) whereas Ins P3 stimulates the release of
Ca2+ from intracellular storage sites. Cell proliferation is an
example ofthe response to the second messenger action. The inner
side of the red cell membrane is laminated with a protein network
that is mainly composed ofspectrin, actin, protein 4.1 and dematin
(4.9 band), so-called 'junctional complex', which stabilizes the
membrane and determines functional integrity (Haest et al, 1978;
Benett et al, 1990; Xiu-Li et al, 1996). Many integral membrane
proteins, such as band 3 protein, glicophorin-A and -C, help
maintain the regular erythrocyte membrane cytoskeleton structure
(Benett, 1981; Sikorski et al, 1993b). Factors that affect the cells
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and cause changes in the spatial structure of membrane superficial
components are reviewed by Fowler (1990) and Michalak and
Sarzala ( 1977). The aim ofour studies was to quantify the changes
in protein and phospholipid content of erythrocyte membranes
from women with ovarian cancer.
MATERIAL AND METHODS
Patients
Studies were carried out on the mature membranes oferythrocytes
sampled from 30 women with ovarian cancer before oophorec-
tomy, aged 24-79 years, treated in the Gynaecology Division,
Chair of Oncology, Karol Marcinkowski University of Medical
Sciences in Poznan. All patients developed the third-degree clin-
ical stage ofepithelial ovarian cancer, according to UICC. Clinical
diagnosis was confirmed by histopathological examination in the
Department of Pathology. Chair of Oncology.
In most women in the third stage of clinical progression of the
ovarian cancer a decrease in values of haemoglobin, haematocrit
and erythrocytes (which are signs of anaemia) was found. Red
blood cell indices in these women were within the low normal
range or had a diminished value. Diminished value ofmean corpus-
cular haemoglobin concentration and mean corpuscular haemo-
globin mass could be the cause ofhypoferraemia, often found in the
advanced stage of cancer. Also, the erythrocyte image in the blood
smear showed microcytosis traits, sometimes poikilocytosis. In
some cases an increased percentage of elliptocytes up to 15% was
found in the blood smear. The percentage of reticulocytes counted
in the blood smear did not deviate from the normal value.
Erythrocytes from 20 healthy women, employed at the
Department of Medical Analytics, Chair of Oncology, were the
control samples.
Erythrocyte membranes isolation
Venous blood samples were taken from women with ovarian
cancer before surgery into 'Vacutainer' tubes pretreated with
EDTA (Sarstedt, Germany).
After centrifugation at 350 g for 30 min, the plasma was
collected in to separate test-tubes, then the upper layer of blood
cells containing granulocytes, lymphocytes, thrombocytes and
reticulocytes was removed. The remaining erythrocytes were
washed twice with natrium chloride isotonic solution. The
samples were then centrifuged at 350g for 10 min and each time
the upper layer of red blood cells was removed. The above proce-
dLire gave a homogeneous suspension of erythrocytes completely
deprived of white blood cells, which was confirmed by micro-
scope examination. The haematocrit value of the erythrocytes
obtained was determined and the red blood cells were then
haemolysed with 20 ml of cold 10 mM Tris, 2 mM EDTA buffer,
pH 7.5. Next, samples were centrifuged at 2°C, 50 000g for
10 min, the supernatant was removed and the sediment containing
erythrocyte membranes was washed twice with 10 ml of the same
cold buffer (Barwijuk et al, 1989).
Phospholipids isolation
Phospholipids were isolated from membranes by the acidic extrac-
tion method (Muller et al, 1986). In two-dimensional thin-layer
chromatography on the plates covered with silica gel, nine
fractions of phospholipids were separated (Broekhuyse, 1969).
The first dimension was developed with chloroform-methanol-
6.5 mM ammonium hydroxide-water (98:74:13:8) and the second
dimension involved the used of chloroform-methanol-14 mm
acetic acid-water (90:13:50: 10)
The separated phospholipid fractions were developed in iodine
vapour then transferred with gel into tubes and I ml of 60% hyper-
chloric acid was added to each tube to mineralize the samples during
I h of heating at 160°C, then the concentration of total phosphorus
was determined (Bartlett, 1959). The obtained value was the base to
quantitative evaluation ofphospholipids in the separated fractions.
Phospholipase C activity measurement
The activity of PLC was determined spectrophotometrically
(Akhrem et al, 1984). PLC activity was expressed as conventional
units (U ml-'), which means the phosphorus quantity released
during 30 min of phospholipid hydrolysis at 37°C to aqueous
phase, in relation to the total phosphorus capacity.
Simultaneously, in the same samples, electrophoretic separation
of membrane proteins was performed in ten women with ovarian
cancer.
SDS-PAGE gel electrophoresis
Red blood cell membranes from patients and healthy donors
were prepared as described previously (Cormingh et al, 1981;
Rybczyrska et al, 1993). Briefly, haemoglobin was removed by
osmotic lysis in 5 mm sodium phosphate buffer, pH 8.0 (5P8)
containing phenylmethylsulfonylfluoride (PMSF) and subsequent
centrifugation at 25 000g for 10 min at 4°C, followed by washing
five times with the same buffer. Protein was determined by the
method of Lowry et al (1951). Red blood cell membranes were
diluted to a concentration of I mg ofprotein I ml-' in SDS sample
buffer (4% SDS, 10% °7-mercaptoethanol, 20% glycerol, 0.005%
bromophenol blue, 100 mM Tris HCI pH 6.8) and solubilized by
incubation for 2 min at 100°C. Separation of membrane proteins
was according to SDS-PAGE protocol performed in 7.5% poly-
acrylamide gel containing 0.1% SDS with 4% acrylamide stacking
gel (Fairbanks et al, 1971). The proteins were stained with
Coomassie brilliant blue R-250 and destained. The protein content
ofeach band was quantified by laser densitometry (LKB Ultrascan)
at 620 nm and expressed as a percentage.
Statistical analysis
Cohran-Cox and Student's t-tests were used for the statistical
analysis.
RESULTS
In thin-layer two-dimensional chromatography nine fractions of
phospholipids were obtained: lecithin phosphatidylcholine (PC),
phosphatidylethanolamine (PE), sphingomyelin (SPH), lysophos-
phatidylcholine (LPC), phosphatidic acid (PA), phosphatidylinositol
(Ptd Ins), phosphatidylinositol-4-phosphate (Ptd Ins-4-P).
phosphatidylinositol-4,5-diphosphate (Ptd Ins-4,5-P2). Our study
showed a significant decrease in phosphatidylserine (PS), SPH,
LPC and PA in erythrocyte membrane of women with ovarian
cancer (Figure 1). The highest reduction (of54%) was observed for
SPH, 43% for PS, 36% for LPC and 25% for phosphatidic acid
concentration. However, the PE concentration in erythrocyte
membranes of cancerous women did not reveal significant differ-
ences as compared with the control group.
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Figure 1 The concentration of phospholipid fraction in erythrocyte
membranes of women with ovarian cancer. Results presented above are
means (+ s.d.) of 30 independent measurements. *Statistically significant
difference, P < 0.05. O, Control; *, malignant
The main changes were obtained in cases of inositol-derived
phospholipid fractions (Figure 2). A statistically significant three-
fold increase in Ptd Ins-4-P and Ptd Ins-4,5-P2 concentrations was
observed with simultaneously reduced level of Ptd Ins in women
with ovarian cancer.
We also found a statistically significant reduction in PLC
activity in erythrocyte membrane of women with ovarian cancer.
The inhibition observed here reached 71% (Figure 2).
The SDS-PAGE method allowed the following fractions to be
separated: spectrin, 2.1 band, 2.2 band, 3 band, 4.1 band, 4.2 band,
5 band and 6 band (Figure 3). There are no qualitative changes in
protein fractions in erythrocyte membranes of women with ovarian
cancer as compared with membrane proteins of healthy women
(Figure 4a and b).
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However, quantitative analysis showed a decrease in spectrin
level by 30% in erythrocyte membrane of cancerous patients as
compared with controls. Simultaneously, a statistically significant
increase in band 4.1 protein was observed (Figure 5).
DISCUSSION
Cancer affects the entire human organism, causing biochemical
changes in various cells and tissues, as well as in erythrocytes. The
erythrocyte membrane is especially liable to activity in extra- and
intracellular factors, which could take part in structural modifica-
tion and conformation of each component (Branton, 1981).
Previous studies have shown that in advanced stages of cancer
changes occur in erythrocyte dimensions and shape, as well as
shortening oflifespan (Miller, 1990; Honda, 1995). Several reasons
for these phenomena are possible. Some authors suppose that
earlier erythrocyte disintegration is a result ofintensive lipid perox-
idation (Roy et al, 1991). Malonyldialdehyde (MDA) is a marker
for lipid peroxidation. A high concentration of MDA in the red
blood cells leads to membrane 'gap' formation and raises cell
susceptibility to haemolysis. Also, MDA, concentration ofwhich is
elevated in erythrocytes of cancerous patients, links amino groups
ofenzymes leading to a decrease in biological activity in these cells
(Lubin, 1981). Another current opinion is that dinucleotide nicotin-
amidoadenine phosphate (NADPH) deficit is responsible for meta-
bolic disturbances in erythrocytes ofcancerous patients (Chien and
Sung, 1990). NADPH is a coenzyme ofglutathione and metheamo-
globin reductases. A decreased level of reduced glutathione is a
reason for some ofthe observed disturbance. These changes are due
to the inhibition of activity of thiol-containing enzymes, e.g.
glucose-6-phosphate dehydrogenase (E.C.1.1.1.49; Chien and
Sung 1990). Many authors also suppose that modification of
protein chemical composition results from the proteolytic activity
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Figure 2 The concentration of inositol-derived phospholipid fractions and phospholipase C activity in erythrocyte membranes of women with ovarian cancer.
Results presented above are means (± s.d.) of 30 independent measurements. *Statistically significant difference, P< 0.05. O, control; *, malignant
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Figure 3 Protein composition of normal and patient red blood cell
membranes. Aliquots of 10 pg each of normal membrane proteins (lane B)
and patients' membrane proteins (lanes C and D) were separated on 7.5%
SDS-PAGE. Lane A, SDS-PAGE molecular standard (high range)
ofenzymes, expression ofwhich on cancer cells is threefold higher
than on normal cells (Michalak et al, 1977). It also seems that
membrane peripheral proteins and phospholipid bilayer are respon-
sible for the normal erythrocyte shape and osmotic resistance main-
tenance (Anderson and Marchesi, 1985; Hanspal and Palek, 1987).
Phospholipids, as a main component of cell membrane, determine
the influence of external factors on intracellular metabolism. Our
studies revealed that in erythrocyte membranes from ovarian
cancerous women statistically significant decreases in PS, SPH,
LPC, PA and Ptd Ins occurred compared with the matched control
group. Simultaneously, a statistically significant increase in phos-
phate derivates of inositol lipids: Ptd Ins-4-P and Ptd Ins-4,5-P2
were observed. PS concentration was significantly lower than in
control subjects. Quantitative changes in erythrocyte membrane
phospholipids resulting from our studies suggest assymetry distur-
bances, which might lead to cytoskeleton reorganization (Byers and
Branton, 1985). SPH plays a fundamental role in this reconstruc-
tion because the hydrogen bonds it forms between the neighbouring
molecules may regulate erythrocyte membrane condition
(Schwartz et al, 1985). Another hypothesis proposes that SPH assy-
metric distribution is supported by the ATP-dependent system of
PS translocation into inner monolayer and PS interaction with
membrane cytoskeleton proteins (Vermeulen, 1996). Spectrin, as a
main element of the cytoskeleton joins the membrane phospho-
lipids by molecules of ankiryn, actin and 4.1 band protein and
affects hydrophobic zone lipid bilayer settlement (Manno et al,
1995). Our densitometric analysis of erythrocyte membrane
proteins showed that the spectrin level decreased by 30% and band
4.1 level increased by 27% as compared with control. These
internal membrane proteins take part in the lipid transport between
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Figure 4 Densitometric scan of the SDS-PAGE protein separations. The
peaks represent the following proteins: A Control, 1, spectrin; 2, band 2.1; 3,
band 2.2; 4, band 3; 5, band 4.1; 6, band 4.2; 7, band 5; 8, band 6. B Patient,
1, spectrin; 3, band 2.1; 4, band 2.2; 5, band 3; 6, band 4.1; 7, band 4.2; 8,
band 5; 9, band 6
plasma and red blood cells and also across the bilayer membrane.
They influence the removal ofdamaged lipid molecules (Chao and
Tao, 1991; Lorenzo et al, 1994). It seems that quantitative changes
in membrane protein in erythrocyte cytoskeleton may negatively
influence the normal membrane organization and erythrocyte
stability. Additional protein fraction of low electrophoretic.
mobility, which migrates more slowly than spectrin on SDS-PAGE,
was found in erythrocyte membranes ofataxia-telangiectasia (A-T)
patients (Rybczyfiska et al, 1990). This phenomenon allows healthy
individuals to be distinguished from A-T patients before the
membrane defect appears. The inherited spectrin deficit may be
connected to the increased red blood cell susceptibility to haemol-
ysis-hereditary spherocytosis (Marchesi et al, 1987). A greater 4.1
band protein level may damage the chemical condition of the
membrane as a consequence of unpaired interaction of 4.1 protein
and myosin (Hanspal and Palek, 1987). Results received up to now
have shown that PS takes part in this transformation, too. The
deficit of PS in the erythrocyte membrane of women with ovarian
cancer can disturb physiological rigidity of the membrane. Less
elastic cell membrane reduces the osmotic resistance and shortens
the erythrocyte lifespan (Rybicki et al, 1988; Pestonjamasp and
Mehta, 1995). Phospholipids, particularly inositol derivates, e.g.
Ptd Ins-4-P and Ptd Ins-4,5-P2, also take part in conformation
changes of erythrocyte membrane proteins. Our study showed Ptd
Ins-4-P and Ptd Ins-4,5-P2 accumulation, which disturbs the
regular polymerization of actin fibre. This fact could be connected
British Journal ofCancer (1998) 78(4), 466-471
*:Ii
0 Cancer Research Campaign 1998470 ZKopczyhski et al
30
25
20
a)
6 15
ca
a) 10
5
0
Spectrin Band 2.1 Band 2.2 Band 3 Band 4.1 Band 4.2 Band 5 Band 6
Figure 5 The concentration of protein fractions in erythrocyte membranes of women with ovarian cancer. The protein content of each band was quantified by
laser densitometry (LKB Ultrascan) at 520 nm and expressed as a percentage. Results presented above are means (± s.d.) of ten independent measurements.
*Statistically significant difference, P < 0.05. D, Control; *, malignant
to the maintenance of erythrocyte physiological shape. However,
Schwartz et al (1985) suggest that diacylglycerol as an intermediate
phosphoinositide degradation product and a strong mediator ofcell
metabolism has a great significance in regular erythrocyte shape
keeping (Muller et al, 1986). We observed that Ptd Ins-4-P and Ptd
Ins-4,5-P2 levels were raised almost threefold in erythrocyte
membranes of women with ovarian cancer compared with control
subjects. High concentrations of membrane inositol lipids could
have many causes. The main cause seems to be PLC inhibition.
This enzyme takes part in the degradation of the phospholipid
component of cell membrane. The PLC substrates are Ptd Ins-4-P
and Ptd Ins-4,5-P2. Our studies showed a 70% decrease in PLC
activity in erythrocyte membranes of women with ovarian cancer.
High levels of Ptd Ins-4-P and Ptd Ins-4,5-P2 can be induced by
intensive activity of PKC. Furthermore, an increase in Ptd Ins-4-P
and Ptd Ins-4,5-P2 levels may be a consequence ofstronger activity
of phosphatidylinositol kinase (E.C.2.7.1.67) and phosphatidyl-
inositol-4-phosphate kinase (E.C.2.7.1.68) (Schwartz et al, 1985).
Phosphorylation processes probably dominate dephosphorylation,
which is then followed by an increase in Ptd Ins-4-P and Ptd Ins-
4,5-P2 levels with a simultaneous Ptd Ins reduction in concentra-
tion. The reason for the PLC inhibition in mature erythrocyte
membranes in cancerous patients has not yet been sufficiently
explained. The literature data reveal that a crucial role in this
process may be played by an increase in quanosine diphosphate
concentration, which is an inhibitor of PLC activity (Bolt et al,
1993). This enzyme can also be inhibited by pH, ionic strength of
intracellular environment and reduction in calcium and magnesium
intracellular concentrations. Quantitative phospholipid changes in
erythrocyte membranes of cancerous women, mainly SPH, PS and
inositol lipid derivates, may influence membrane cytoskeleton reor-
ganization. Phospholipid changes are accompanied by differences
in structural proteins, observed in our studies. Altogether, they may
contribute to the essential erythrocyte membrane property distur-
bances and could influence activity and integrality of red blood
cells. These quantitative changes may be associated with perma-
nent or transient anaemia in women with ovarian cancer.
ABBREVIATIONS
LPC, lysophosphatidylcholine; MDA, malonyldialdehyde; PA,
phosphatidic acid; PC phosphatidylcholine; PS, phosphatidylserine;
SPH, sphingomyelin; Ptd Ins, phosphatidylinositol; Ptd Ins-4-P,
phosphatidylinositol-4-phosphate; Ptd Ins-4,5-P2, phosphatidyl-
inositol-4,5-diphosphate; PE, phosphatidylethanolamine; PLC,
phospholipase C, PKC, protein kinase C.
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